[1]
“Induction of cell death in prostate cancer cells by escopoletin, a promising treatment strategy”, Bangladesh J Pharmacol, vol. 10, no. 3, pp. 500–504, Jul. 2015, doi: 10.3329/bjp.v10i3.23095.